Skip to main content
# Title Department Research Year
2661 Evaluation of a Novel Vaginal Bromocriptine Mesylate Formulation: A Pilot Study. Department of Clinical Pharmacy 2005
2662 Formulation and Evaluation of Famotidine Sublingual Tablets.


Department of Pharmaceutics 2005
2663 Allophenylnorstatine-containing HIV-1 protease inhibitors: design,synthesis and structure activity relationships for selected P2 ligands.
Department of Medicinal Chemistry 2005
2664 Hepatic effects of novel selenazolidine prodrugs of selenocysteine developed as potential cancer chemopreventive agents. Department of Medicinal Chemistry 2005
2665 Enhanced delivery of c-secretase inhibitor DAPT into the brain via an ascorbic acid mediated strategy Department of Medicinal Chemistry 2005
2666 Solubilization of some non-steriodal anti-inflammatory drugs (NSAIDs) by pluronic F-127 block copolymer. Department of Pharmaceutics 2004
2667 Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels, Department of Pharmaceutics 2004
2668 Optical Isomers of 3-substituted-5-(2-carboxyethyl)-1,3,5- thiadiazin-2-thiones of Potential Antimicrobial Activity, Synthesis, and Solid State Stability. Department of Industrial Pharmacy 2004
2669 Phase II Drug Metabolizing Enzyme mRNA Changes by Novel Selenazolidine Prodrugs of Selenocysteine in Mice. Department of Medicinal Chemistry 2004
2670 Development and evaluation of chitosan films of potential topical application. Department of Pharmaceutics 2004